If a baby has fast or labored breathing, pauses in breathing, bluish lips or poor feeding, call 911 or go to the emergency department. Trouble breathing, chest pain or pressure, or fainting at any age means the same thing, call 911 or go to the emergency department.
A result is one piece of information. The clinician who ordered the test decides what it reflects and what happens next.
An RSV test looks for the virus itself in fluid from the nose or the back of the throat, either its genetic material or the proteins sitting on its surface. It is not looking at how sick someone is, and it is not looking at the body's response to the virus.
Respiratory syncytial virus is an RNA virus that infects the cells lining the airway, starting in the nose and able to spread down into the smaller airways of the lung. Two groups of the virus, RSV-A and RSV-B, circulate in people, and research suggests both groups co-circulate with patterns that shift between seasons 1. Because the virus multiplies in the lining of the nose and throat, that is where the sample comes from.
There are two routes a laboratory takes. A molecular test, almost always a PCR, copies any RSV genetic material in the sample over and over until there is enough of it to register on an instrument. An antigen test uses antibodies fixed to a strip or a cartridge that bind RSV surface proteins and generate a line or a reader signal. Earlier laboratory work on RSV leaned on growing the virus in cell culture and on immunofluorescence staining of nasopharyngeal secretions 2, approaches that still exist in specialist laboratories but that have been displaced in day to day care by faster formats.
Blood testing for RSV antibodies is a different question. It looks at the immune response over time rather than at virus present in the airway right now, and it is not the test a clinic reaches for when someone is coughing today. Research suggests immunity after an RSV infection is incomplete, so a person can be infected again in later seasons 2, which is one reason a past infection does not answer the question about a current illness.
Testing is considered when someone has a respiratory illness and the result would change what happens next, and that is more likely in infants and young children, in older adults, and in people living with chronic lung disease, heart disease or weakened immunity.
In babies, RSV can move beyond the nose into the small airways, which is why a clinician may want to know which virus is involved before deciding on monitoring, admission or isolation in a hospital setting. Research suggests RSV testing practices in children under five vary across care settings, and that reported infection numbers depend on which tests are used and on who gets tested in the first place 3. Put plainly, the picture of RSV in young children is shaped by testing habits as much as by the virus.
In older adults, the same symptoms can be put down to a chest infection or a flare of an existing lung condition without anyone looking for a specific virus. Studies indicate that RSV in older adults goes under-recognised without deliberate testing, and a multidisciplinary panel has set out recommendations aimed at closing that gap 4.
Outside those groups, a healthy adult with a mild cold is not automatically swabbed, because the result would not change the care they receive. Testing becomes worth discussing when symptoms are getting worse rather than better, when someone lives or works with a newborn or a frail older adult, or when a clinician is weighing a respiratory illness against an existing heart or lung condition. The decision sits with the clinician, who is also weighing what else could be causing the symptoms.
The sample is collected from the nose, the nasopharynx at the back of the nasal cavity, or the throat, depending on the test being run and the age of the person.
A nasopharyngeal swab is passed along the floor of the nostril, back toward the rear of the nasal cavity rather than upward, rotated to pick up cells and secretions, then withdrawn and placed into a tube of transport fluid. An anterior nasal swab stays in the front of the nostril and is simpler to collect. A nasal wash or aspirate, where a small amount of sterile saline is instilled and then drawn back, is one of the collection methods used in infants, and historic laboratory work on RSV was built around nasopharyngeal secretions collected this way. In hospital, a clinician may collect a sample from lower in the airway when someone has significant lower airway disease.
Sample quality matters, because a test can only find virus that made it into the tube. A swab that does not reach secretions, a sample left in the wrong conditions, or a tube filled after symptoms have been running for a while can all come back negative while the person is still unwell.
For a child, the collection is handled by the clinician or nurse, with a parent holding or steadying the child. Ask your child's pediatrician what the swab involves at that clinic, which sample type they use, and who will call with the result.
They differ in what they detect, where they are run and how reliably they pick up the virus, with the molecular route detecting viral genetic material and the rapid route detecting viral proteins.
| Feature | Nose or nasopharyngeal swab run by PCR | Rapid antigen test |
|---|---|---|
| What it detects | RSV genetic material, copied until detectable | RSV surface proteins bound by antibodies on a strip or cartridge |
| Where it runs | A laboratory instrument, either on site or at a reference laboratory | At the point of care, on a small device or visual strip 7 |
| When the result arrives | Depends on the laboratory and on whether the sample is sent out, so ask the ordering clinic | Within the same visit |
| Detection in young children | Research suggests molecular testing detects RSV in children more sensitively than antigen testing 5 | Research suggests antigen tests perform better in children than they do in adults 6 |
| Detection in adults | The route a clinician can turn to when an antigen result is negative and suspicion remains | Research suggests antigen tests detect RSV less reliably in adults 6 |
| Multiple viruses from one swab | Many PCR panels cover influenza and SARS-CoV-2 alongside RSV | Single target or small combination formats |
The practical trade is speed against sensitivity. A point of care antigen test puts an answer in the room while the person is still there, which is why these formats moved out of the laboratory and toward the bedside in the first place 7. A PCR adds a step and a wait, and buys detection of smaller amounts of virus. A clinician chooses between them based on the person in front of them, not on a blanket rule.
Turnaround depends on the test format and on where the sample is run, so the reliable answer is to ask the ordering clinic what to expect for that specific laboratory.
A rapid antigen test is designed to be read during the same visit, on a strip or a small bench reader, without the sample leaving the room. A PCR run on an instrument inside the clinic or hospital returns within the same episode of care in many settings. A PCR sent to an external reference laboratory adds transport and batching time, and that leg varies with distance, courier schedules and how busy the laboratory is during a respiratory season.
Two other things stretch the clock. Multiplex panels that cover several respiratory viruses from one swab can be run in batches rather than one at a time. And the result still has to be reviewed and communicated, which is a separate step from the laboratory finishing the run.
If a result is being used to make a decision about a baby or an older adult who is deteriorating, do not wait on it. Clinical signs drive urgent decisions, and emergency signs mean call 911 or go to the emergency department regardless of whether a test has come back.
Home respiratory test kits that include RSV exist, and what is available to buy depends on where you are and on what the regulator in that country has authorised, so check the product labelling and the regulator's own listing before relying on one.
The mechanics match the clinic version. A nasal swab is collected, placed into a buffer, and applied to a strip or small reader that looks for RSV proteins rather than genetic material. The format is the rapid antigen route, with the same ceiling on detection. Research suggests rapid antigen testing detects RSV less reliably in adults than in children 6, which matters because an adult is the person likely to be swabbing themselves at home.
The second limitation is interpretation. A clinic result arrives attached to someone who examined the person, knows their history and can act on the finding. A home result arrives on a kitchen counter. A positive tells you the kit detected RSV proteins in that sample. A negative does not rule out RSV, and it does not rule out influenza, SARS-CoV-2 or anything else going on at the same time.
Use a home kit as information to bring to a clinician, not as a substitute for being seen. For a baby or an older adult with worsening symptoms, go to a clinician rather than swab again, and for the emergency signs listed on this page, call 911 or go to the emergency department.
Yes, timing matters, because a swab can only detect virus that is being shed into the airway at the moment the sample is taken.
The amount of virus in nasal secretions rises and falls across an illness rather than holding steady. A swab collected before symptoms have fully declared themselves, or well into recovery when the airway has cleared much of the virus, can come back negative while the person still feels unwell.
This is one reason a clinician pairs the result with the story. Day of illness, whether symptoms are climbing or settling, who else in the household is sick, and whether there is an underlying lung or heart condition all change how a negative is read.
It is also why repeating a test is sometimes the next step rather than accepting the first answer. If symptoms are escalating after an early negative, a clinician may re-swab, switch to a molecular test, or test for other respiratory viruses instead. That decision belongs to the clinician, who weighs whether a different answer would actually change care.
A positive result reports that RSV was detected in that sample at that time. It is the laboratory describing what was in the tube, and the clinician who ordered it decides what the finding reflects for that person.
A positive narrows the field. It gives a name to the illness, which can inform infection control at home and in hospital, guide whether contact with a newborn or a frail older adult should be limited for a period, and reduce the hunt for other explanations. It does not forecast how the illness will unfold, and it does not grade severity. Severity is judged from breathing, feeding, hydration, alertness and examination, not from a strip or a cycle number.
One virus detected does not exclude another. Respiratory viruses can be present together, which is part of why multiplex panels exist. A positive also does not override a worsening clinical picture. If a baby who has tested positive develops fast or labored breathing, pauses in breathing, bluish lips or poor feeding, call 911 or go to the emergency department.
Any next step after a positive, including whether anything is prescribed and whether monitoring moves to a hospital, is a clinician's call. Treatment decisions belong to a licensed provider, and some medicines interact with how an illness is managed, so ask your prescriber about anything already being taken.
A negative result reports that RSV was not detected in that sample at that time. It is not a statement that the person does not have RSV, and it is not a statement that nothing is wrong.
Several things sit behind a negative. The sample may have been collected before or after the window when virus was being shed in detectable amounts. The swab may not have reached secretions. The format may have a lower ceiling on detection than a molecular test, which is where the gap between antigen and PCR testing shows up. And the illness may be caused by something other than RSV, which a single-target test cannot speak to at all.
In adults specifically, a single negative swab carries less weight. Studies suggest adult RSV infection is under-ascertained when detection relies on one swab and one method, with more infections identified when additional sample types or testing methods are added 8.
The practical rule is simple. A negative test does not cancel symptoms. If breathing, feeding or alertness changes, or if the illness keeps climbing instead of settling, go back to the clinician rather than relying on the earlier result, and treat emergency signs as emergency signs.
RSV is harder to detect in adults than in young children because the amount of virus reaching the swab is smaller, and because the test formats that are quickest to run are the ones that struggle at low levels.
Young children shed larger quantities of virus into the nose, which is friendly territory for an antigen strip. Adults present a thinner signal. Research suggests rapid antigen tests detect RSV less reliably in adults than in children 6, and studies suggest adult infections are under-ascertained when testing is limited to a single nasal swab and a single method 8.
There is a second, non-biological reason. Adults with a cough and a fever are not always swabbed at all, and an illness that is never tested is never counted. Studies indicate that RSV in older adults goes under-recognised without deliberate testing 4, which compounds the detection problem built into the test formats.
For an adult with a chronic lung condition, heart disease or weakened immunity, the takeaway is to raise the question rather than wait for it to be offered. Ask whether a molecular test is appropriate, and ask what a negative would and would not settle.
Routine clinical testing reports RSV as detected or not detected and does not break the result into subgroup A or subgroup B.
The two subgroups differ in their surface proteins and in how they move through a season. Research suggests RSV-A and RSV-B co-circulate with patterns that shift between seasons, while reported differences in clinical severity between the two are not consistent across reports 1.
For someone sitting in a clinic with a sick infant, this is background rather than foreground. Knowing the subgroup would not change the monitoring, the examination findings a clinician is watching for, or the threshold for calling 911. It matters at the population level, where tracking which group is circulating feeds into surveillance and prevention planning.
If a laboratory report does include a subgroup, read it as a laboratory detail and bring any questions about it to the clinician who ordered the test.
The swab and the mechanics are close to identical. What differs is the target the test is tuned to find, and whether the laboratory is looking for one virus or several from the same sample.
RSV, influenza and SARS-CoV-2 can produce overlapping symptoms, which is why multiplex PCR panels that cover all three from one swab are used widely in clinics and hospitals. A single-target RSV test will not report influenza, and a single-target influenza test will not report RSV, no matter how suggestive the symptoms are. If you want the fuller picture of what a respiratory swab can and cannot answer, the companion guide to the flu test covers the same ground for influenza.
The differences that matter in practice are these. A single negative on one target leaves the other viruses untested unless a panel was run. Rapid antigen formats exist for all three and share the same trade of speed against sensitivity. And the clinical decisions that follow a result differ by virus, because what a clinician does next is not the same for an infant with RSV and an older adult with influenza.
Ask the clinic which targets their panel covers. That one question avoids reading a negative as broader than it is.
A white blood cell count measures the number of white cells circulating in a blood sample, and it is a general marker of what the immune system is doing rather than a test for any specific virus. It will not identify RSV, and it cannot separate one respiratory infection from another on its own.
Total WBCs is covered in full on its own page, including what it measures, how the blood draw is done and how the numbers are read. Values are interpreted against the range as printed on your lab report, and for a child, with the child's pediatrician, because the figures that apply to adults do not carry over to infants and young children.
A clinician may order blood work alongside a swab when someone is unwell enough to need a broader assessment. The swab answers the virus question. The blood work answers a different one.
Some signs mean emergency services, with no softer alternative. Others mean getting seen, and the two lists are not interchangeable.
Call 911 or go to the emergency department for any of these.
Contact a clinician promptly, the same day where possible, for these.
This page is health education and is not medical advice. Discuss any test result, symptom or treatment question with a clinician or licensed provider who knows the person involved.
The clinician reads the result against the examination and the history, and decides whether anything changes. A result on its own does not generate a plan.
For a child, that conversation belongs with the pediatrician, who assesses breathing, feeding, hydration and alertness, sets out what to watch for at home, and says when to come back or when to go straight to emergency care. Ask what specifically would mean returning sooner, and write it down. For an adult with a chronic lung or heart condition, the clinician may adjust monitoring, arrange review, or look for other contributing causes. Treatment decisions belong to a licensed provider in every case, and some medicines interact with how an acute illness is handled, so ask your prescriber rather than adjusting anything independently.
It is also worth knowing what the result does not do. It does not predict how the illness will run, and it does not replace the next assessment if things change. Research suggests molecular testing detects RSV in children more sensitively than antigen testing 5, but even the most sensitive swab describes one moment in time.
Acute infection testing sits outside routine optimization bloodwork. FitScript is a labs-first membership covering 150+ biomarkers tested per year, with interpretation by Atlas, FitScript's AI health advisor, and that is a different question from identifying a virus during an illness this week. The swab belongs to the clinic treating the illness.
It checks a sample of fluid from the nose or the back of the throat for respiratory syncytial virus, either the virus's genetic material or proteins on its surface. It does not measure how severe an illness is. The clinician who ordered it decides what the result reflects for that person.
It depends on the format and on where the sample is run, so ask the ordering clinic what to expect for their laboratory. A rapid antigen test is designed to be read during the same visit. A PCR sent to an outside laboratory adds transport and processing time before anyone can call you with a result.
From the nostril, from the nasopharynx at the back of the nasal cavity, or from the throat, depending on the test. In infants, a nasal wash or aspirate using a small amount of sterile saline is one of the collection methods used. Ask the clinic which sample type they collect.
Home kits that include RSV exist, and what is available depends on where you live and on what the regulator there has authorised, so check the product labelling first. A home kit uses the rapid antigen format, which has a lower ceiling on detection than a laboratory molecular test. Bring any home result to a clinician rather than acting on it alone.
Yes. A negative reports only that virus was not detected in that sample at that moment, and timing of the swab, sample quality and the test format all affect detection. If symptoms keep climbing after a negative, go back to the clinician instead of relying on the earlier result.
Adults are tested when the result would change their care, which is more likely in older adults and in people living with chronic lung disease, heart disease or weakened immunity. Detection in adults is harder than in children because less virus reaches the swab. Ask whether a molecular test is appropriate and what a negative would and would not settle.
That decision belongs with your child's pediatrician, who weighs the child's age, breathing, feeding and overall condition against what a result would change. If a swab is done, ask who will call with the result and what signs mean coming back sooner. Fast or labored breathing, pauses in breathing, bluish lips or poor feeding mean call 911 or go to the emergency department.
The swab and the mechanics are close to identical, and the difference is which virus the test is tuned to find. A single-target RSV test will not report influenza, and the reverse is also true. Many clinics run a multiplex panel that covers RSV, influenza and SARS-CoV-2 from one swab, so ask which targets their panel includes.